New analysis from Vanderbilt Well being reveals that each fashionable weight reduction medicine and bariatric (weight reduction) surgical procedure can enhance physique composition in folks with weight problems. These remedies result in a big drop in fats whereas additionally inflicting a smaller discount in fat-free mass (together with lean muscle).
This steadiness issues as a result of physique composition performs a serious function in long-term well being. The next proportion of fats mass (FM) is linked to a higher danger of dying from obesity-related circumstances, together with cardiovascular issues. In distinction, a better proportion of fat-free mass (FFM) is related to a decrease danger of dying.
Why Fats Loss and Muscle Preservation Matter
The findings spotlight an essential tradeoff. Whereas decreasing fats is helpful, sustaining lean mass can be vital for general well being and survival. Understanding how these two parts change with totally different remedies stays an lively space of analysis.
The researchers famous that extra research are wanted to raised perceive how FM and FFM shift after bariatric surgical procedure or therapy with GLP-1 receptor agonist medicine in real-world medical settings. Their findings have been printed in JAMA Community Open.
Research Design and Affected person Knowledge
The research was led by Danxia Yu, PhD, affiliate professor of Medication within the Division of Epidemiology, and Jason Samuels, MD, assistant professor of Surgical procedure.
Researchers performed a retrospective evaluation utilizing digital well being information. The research included 1,257 sufferers between the ages of 18 and 65 who underwent bariatric surgical procedure at Vanderbilt Well being from 2017 to 2022. It additionally included 1,809 sufferers handled with the medicine semaglutide or tirzepatide from 2018 to 2023.
People with a historical past of end-stage renal illness or congestive coronary heart failure have been excluded from the evaluation.
To guage adjustments in physique composition, the researchers used bioelectrical impedance evaluation. This methodology estimates FM and FFM based mostly on particular person traits resembling peak, weight, age, race, gender, historical past of diabetes, and length of GLP-1 therapy.
Key Findings Over 24 Months
Over a 24-month interval, each therapy approaches produced comparable patterns. Sufferers skilled substantial reductions in FM together with modest decreases in FFM. On the identical time, the ratio of FFM to FM elevated, indicating an general enchancment in physique composition.
The research additionally discovered variations between women and men. Male sufferers tended to protect fat-free mass extra successfully over the long run in comparison with feminine sufferers.
Analysis Crew and Funding
The primary authors of the research have been graduate scholar Zicheng Wang, MS, and postdoctoral fellow Lei Wang, PhD, each in Epidemiology.
Further contributors included Xinmeng Zhang and You Chen, PhD (Biomedical Informatics and Pc Science); Brandon Lowery (Vanderbilt Institute for Scientific and Translational Analysis); Lauren Lee Shaffer, MS, and Quinn Wells, MD (Cardiovascular Medication); and Charles Flynn, PhD, Brandon Williams, MD, Matthew Spann, MD, and Gitanjali Srivastava, MD (Surgical procedure).
The analysis was supported partially by Nationwide Institutes of Well being grants R01DK126721 and R01CA275864.
